Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Nora PashayanNora Pashayan 

Personalised or risk-stratified screening offers opportunities to improve the efficiency of cancer screening programmes and reduce their adverse consequences.  Polygenic risk score alone or combined with non-genetic risk factors could be used for risk-stratification for risk-tailored screening.  Developing and implementing such risk-stratified programmes would require coordination of multi-disciplinary efforts.

Further information.

Forthcoming events

The burden of drug resistant infections, the GRAM project

Monday, 16 June 2025, 1pm to 2pm @ BDI/OxPop Building LG seminar rooms

Building virtual cells for precision oncology

Tuesday, 17 June 2025, 1pm to 2pm @ Richard Doll lecture theatre